| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |